AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,342 | 41,205 | 87,435 | 33,099 | 89,953 |
| Marketable Securities | 77,993 | 146,774 | 27,351 | 95,359 | 126,916 |
| Receivables | 1,180 | 1,254 | 17,179 | 411 | 468 |
| Other current assets | 435 | 1,248 | 274 | 428 | 1,067 |
| TOTAL | $116,744 | $195,368 | $139,408 | $134,230 | $221,702 |
| Non-Current Assets | |||||
| PPE Net | 2,401 | 3,011 | 3,761 | 4,463 | 5,597 |
| Investments And Advances | 705 | 471 | 402 | 378 | 397 |
| Intangibles | 60,852 | 57,268 | 56,158 | 52,831 | 55,160 |
| Other Non-Current Assets | 5,480 | 6,176 | 3,908 | 2,943 | 3,188 |
| TOTAL | $69,438 | $66,926 | $64,229 | $60,615 | $64,343 |
| Total Assets | $186,181 | $262,294 | $203,637 | $194,844 | $286,045 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,496 | 3,019 | 1,870 | 974 | 2,192 |
| Accrued Expenses | 9,737 | 13,742 | 12,350 | 9,868 | 18,311 |
| TOTAL | $114,294 | $114,542 | $15,122 | $12,031 | $21,911 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 101,033 | 96,615 | 154 | 615 | 785 |
| Other Non-Current Liabilities | 14,888 | 15,045 | 9,574 | 5,728 | 10,326 |
| TOTAL | $17,712 | $20,225 | $9,574 | $5,728 | $10,326 |
| Total Liabilities | $132,006 | $134,767 | $24,696 | $17,759 | $32,237 |
| Shareholders' Equity | |||||
| Common Shares | 2,719 | 2,529 | 2,327 | 1,883 | 1,963 |
| Retained earnings | -529,898 | -418,283 | -352,212 | -276,661 | -219,851 |
| Other shareholders' equity | -255 | -253 | -174 | -120 | -136 |
| TOTAL | $54,175 | $127,528 | $178,940 | $177,086 | $253,808 |
| Total Liabilities And Equity | $186,181 | $262,294 | $203,637 | $194,845 | $286,045 |